Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Disappointing phase III results for Bayer anti-TNF antibody

May 22, 1997

FDA reschedules review date for Heart Laser

May 22, 1997

UR-12670 effective in rat model of endotoxic shock

May 22, 1997

Na+/H+ exchange inhibitors reported by Hoechst

May 22, 1997

Additional GUSTO III data supports efficacy and safety of Retavase

May 21, 1997

Design of bisoprolol CIBIS II study

May 21, 1997

Orion-Yhtyma discloses potent and selective alpha2-adrenoceptor agonists

May 21, 1997

Peptide P-selectin inhibitors described by Centocor

May 20, 1997

BMS describes angiotensin II antagonists

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...